Ask AI
ProCE Banner Activity

Expert Guidance in IgAN Management: Risk Stratification and Treatment Pearls

Clinical Thought

Get an expert’s perspective on IgA nephropathy (IgAN)! Learn about biomarkers for predicting progression risk, considerations for incorporating new therapies into practice, and important roles for advanced practice providers in caring for patients with IgAN.

Released: June 24, 2025

Expiration: June 25, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Disclosure

Primary Author

Pietro Canetta, MD, MS: consultant/advisor/speaker: Otsuka, Takeda, Travere, Vera Therapeutics.